866-997-4948(US-Canada Toll Free)

HIV/AIDS Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Jul 2017

Category :

In Vitro Diagnostics

No. of Pages : 167 Pages

Global HIV/AIDS Diagnostics Market: Overview

This report provides forecast and analysis of the HIV/AIDS diagnostics market on the global and regional levels. It provides historical data of 2016 along with forecast from 2017 to 2025 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on HIV/AIDS diagnostics globally. It includes drivers and restraints of the HIV/AIDS diagnostics market and their impact on each region during the forecast period. The report also comprises of the study of current issues with end users and opportunities for HIV/AIDS diagnostics manufacturers in the global market.

In order to provide users with comprehensive view of the market, we have included detailed competitive analysis and market players with unique selling propositions. The competitive dashboard included in the report provides detailed comparison of HIV/AIDS diagnostics manufacturers on parameters such as product offerings, revenue, key strategies, and recent developments. The study encompasses market attractiveness analysis, by product type, by test type, by end users and region.

Global HIV/AIDS Diagnostics Market: Research Methodology

Market value for global HIV/AIDS diagnostics have been estimated based on utility of HIV/AIDS diagnostics for all product types. The revenue is forecasted through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The HIV/AIDS diagnostic market has been analyzed based on expected demand. Most of the key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of HIV/AIDS diagnostics in different regions.

Bottom-up approach has been used to estimate the HIV/AIDS diagnostics market size, and top-down approach has been used to validate the market number. The market has been forecasted based on constant currency rates. A number of secondary sources consulted during the course of the study include Factiva, NCBI, Google books, company annual reports, websites, white papers, and publications.

Global HIV/AIDS Diagnostics Market: Segmentation

The report includes revenue generated from sales of HIV/AIDS diagnostics in all regions and important countries in the regions. By product type, the global HIV/AIDS diagnostics market has been segmented into kits and reagents, instruments and others. On the basis of test type the HIV/AIDS diagnostics market is segmented into rapid tests (POC), ELISA, nucleic acid tests and others. On the basis of end users, the global HIV/AIDS diagnostics market is segmented into hospitals, private diagnostics laboratories, academic and research institutes and others. Geographically, the market is segmented into regions viz. North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Global HIV/AIDS Diagnostics Market: Competitive Analysis

The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global HIV/AIDS diagnostics market include Alere, Hologic, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Abbott Laboratories, Siemens Healthineers, OraSure Technologies, Inc., Chembio Diagnostic Systems etc.

The global HIV/AIDS diagnostics market is segmented as follows:

Global HIV/AIDS Diagnostics Market – By Product Type

  • Kits and Reagents
  • Instruments
  • Others

Global HIV/AIDS Diagnostics Market – By Test Type

  • Rapid Tests (POC)
  • ELISA
  • Nucleic Acid Tests
  • Others

Global HIV/AIDS Diagnostics Market – By End Users

  • Hospitals
  • Private Diagnostics Laboratories
  • Academic and Research Institutes
  • Others

Global HIV/AIDS Diagnostics Market – By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global HIV/AIDS Diagnostics Market

4. Market Overview

4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Economic Drivers
4.2.1.2. Supply Side Drivers
4.2.1.3. Demand Side Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Key Trends

5. Global HIV/AIDS Diagnostics Market Analysis and Forecast, 2017-2025
5.1. Market Revenue Projections (US$ Mn)
5.2. Porter’s Five forces Analysis: Global HIV/AIDS Diagnostics Market
5.3. Recent Development (Industry Updates, Merger & Acquisition)
5.4. Global HIV/AIDS Epidemiology
5.5. Disease Overview
5.6. Preventive Measures for HIV/AIDS
5.7. Future Market Outlook

6. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value (US$ Mn) Forecast By Product Type
6.3.1. Kits and Reagents
6.3.2. Instruments
6.3.3. Others
6.4. Market Attractiveness by Product Type

7. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value (US$ Mn) Forecast By Test Type
7.3.1. Rapid Tests (POC)
7.3.2. ELISA
7.3.3. Nucleic Acid Tests
7.3.4. Others
7.4. Market Attractiveness by Test Type

8. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value (US$ Mn) Forecast By End User
8.3.1. Hospitals and Clinics
8.3.2. Private Diagnostic Laboratories
8.3.3. Academic and Research Institutes
8.3.4. Others
8.4. Market Attractiveness by End User

9. Global HIV/AIDS Diagnostics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value (US$ Mn) Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East and Africa
9.3. Market Attractiveness by Region

10. North America HIV/AIDS Diagnostics Market Analysis and Forecast
10.1. Key Findings
10.2. Market Value (US$ Mn) Forecast By Country
10.2.1. U.S.
10.2.2. Canada
10.3. Market Value (US$ Mn) Forecast By Product Type
10.3.1. Kits and Reagents
10.3.2. Instruments
10.3.3. Others
10.4. Market Value (US$ Mn) Forecast By Test Type
10.4.1. Rapid Tests (POC)
10.4.2. ELISA
10.4.3. Nucleic Acid Tests
10.4.4. Others
10.5. Market Value (US$ Mn) Forecast By End User
10.5.1. Hospitals and Clinics
10.5.2. Private Diagnostic Laboratories
10.5.3. Academic and Research Institutes
10.5.4. Others
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Test Type
10.6.4. By End User

11. Europe HIV/AIDS Diagnostics Market Analysis and Forecast
11.1. Key Findings
11.2. Market Value (US$ Mn) Forecast By Country
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Spain
11.2.5. Italy
11.2.6. Rest of Europe
11.3. Market Value (US$ Mn) Forecast By Product Type
11.3.1. Kits and Reagents
11.3.2. Instruments
11.3.3. Others
11.4. Market Value (US$ Mn) Forecast By Test Type
11.4.1. Rapid Tests (POC)
11.4.2. ELISA
11.4.3. Nucleic Acid Tests
11.4.4. Others
11.5. Market Value (US$ Mn) Forecast By End User
11.5.1. Hospitals and Clinics
11.5.2. Private Diagnostic Laboratories
11.5.3. Academic and Research Institutes
11.5.4. Others
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Test Type
11.6.4. By End User

12. Asia Pacific HIV/AIDS Diagnostics Market Analysis and Forecast
12.1. Key Findings
12.2. Market Value (US$ Mn) Forecast By Country
12.2.1. China
12.2.2. Japan
12.2.3. India
12.2.4. Australia & New Zealand
12.2.5. Rest of Asia Pacific
12.3. Market Value (US$ Mn) Forecast By Product Type
12.3.1. Kits and Reagents
12.3.2. Instruments
12.3.3. Others
12.4. Market Value (US$ Mn) Forecast By Test Type
12.4.1. Rapid Tests (POC)
12.4.2. ELISA
12.4.3. Nucleic Acid Tests
12.4.4. Others
12.5. Market Value (US$ Mn) Forecast By End User
12.5.2. Private Diagnostic Laboratories
12.5.3. Academic and Research Institutes
12.5.4. Others
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Test Type
12.6.4. By End User

13. Latin America HIV/AIDS Diagnostics Market Analysis and Forecast
13.1. Key Findings
13.2. Market Value (US$ Mn) Forecast By Country
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Market Value (US$ Mn) Forecast By Product Type
13.3.1. Kits and Reagents
13.3.2. Instruments
13.3.3. Others
13.4. Market Value (US$ Mn) Forecast By Test Type
13.4.1. Rapid Tests (POC)
13.4.2. ELISA
13.4.3. Nucleic Acid Tests
13.4.4. Others
13.5. Market Value (US$ Mn) Forecast By End User
13.5.1. Hospitals and Clinics
13.5.2. Private Diagnostic Laboratories
13.5.3. Academic and Research Institutes
13.5.4. Others
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Product Type
13.6.3. By Test Type
13.6.4. By End User

14. Middle East and Africa HIV/AIDS Diagnostics Market Analysis and Forecast
14.1. Key Findings
14.2. Market Value (US$ Mn) Forecast By Country
14.2.1. Saudi Arabia
14.2.2. South Africa
14.2.3. Rest of MEA
14.3. Market Value (US$ Mn) Forecast By Product Type
14.3.1. Kits and Reagents
14.3.2. Instruments
14.3.3. Others
14.4. Market Value (US$ Mn) Forecast By Test Type
14.4.1. Rapid Tests (POC)
14.4.2. ELISA
14.4.3. Nucleic Acid Tests
14.4.4. Others
14.5. Market Value (US$ Mn) Forecast By End User
14.5.1. Hospitals and Clinics
14.5.2. Private Diagnostic Laboratories
14.5.3. Academic and Research Institutes
14.5.4. Others
14.6. Market Attractiveness Analysis
14.6.1. By Country
14.6.2. By Product Type
14.6.3. By Test Type
14.6.4. By End User

15. Competition Landscape
15.1. Market Player- Competition Matrix
15.2. Market Share Analysis by Company (2016)
15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.1.4 Financial Overview
15.3.1.5 Strategic Overview
15.3.2. Hologic, Inc.
15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.2.4 Financial Overview
15.3.2.5 Strategic Overview
15.3.3. Alere, Inc.
15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.3.4 Financial Overview
15.3.3.5 Strategic Overview
15.3.4. Bio-Rad Laboratories
15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.4.4 Financial Overview
15.3.4.5 Strategic Overview
15.3.5. Abbott Laboratories
15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.5.4 Financial Overview
15.3.5.5 Strategic Overview
15.3.6. Siemens Healthineers
15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.6.4 Financial Overview
15.3.6.5 Strategic Overview
15.3.7. OraSure Technologies, Inc.
15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.7.4 Financial Overview
15.3.7.5 Strategic Overview
15.3.8. Chembio Diagnostic Systems
15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.8.4 Financial Overview
15.3.8.5 Strategic Overview
15.3.9. Danaher Corporation (Cepheid)
15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2 Product Portfolio
15.3.9.3 SWOT Analysis
15.3.9.4 Financial Overview
15.3.9.5 Strategic Overview
15.3.10. Becton, Dickinson and Company
15.3.10.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2 Product Portfolio
15.3.10.3 SWOT Analysis
15.3.10.4 Financial Overview
15.3.10.5 Strategic Overview
15.4. Key Takeaways

List of Table

Table 01: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016-2025
Table 02: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 03: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 04: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2025
Table 05: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 06: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016-2025
Table 07: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 08: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 09: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 10: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 11: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 12: Europe HIV/AIDS Diagnostic Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 13: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 14: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 15: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 16: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 17: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 18: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 19: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 20: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 21: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 22: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 23: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 24: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025

List of Chart

Figure 01: Market Size, by Test Type (US$ Mn), 2016
Figure 02: Market Share, Top Trends by Product Type
Figure 03: Market Share by Region, 2016
Figure 04: Market Share Analysis by Region
Figure 05: Key Industry Developments
Figure 06: Porter’s Five Forces Analysis 
Figure 07: Global HIV/AIDS Diagnostics Market Size (US$ Mn) and Forecast, 2016–2025
Figure 08: Preventive Measures for HIV/AIDS
Figure 09: Global Market Value Share, by Product type (2016)
Figure 10: Global Market Value Share, by Test Type (2016)
Figure 11: Global Market Value Share, by End users (2016)
Figure 12: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025 Analysis
Figure 13: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits and Reagents, 2015–2025
Figure 14: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), Reagents, by Instruments, 2015–2025
Figure 15: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 16: HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 17: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 18: Global HIV/AIDS Diagnostic Market Revenue, by Rapid Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global HIV/AIDS Diagnostic Market Revenue, by ELISA (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global HIV/AIDS Diagnostic Market Revenue, by Nucleic Acid Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global HIV/AIDS Diagnostic Market Revenue, by Others Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017 -2025
Figure 23: Global HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 24: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 25: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Private Diagnostic Laboratories, 2015–2025 
Figure 26: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2015–2025
Figure 27: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 28: Global HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-user, 2017-2025
Figure 29: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Region, 2016 and 2025
Figure 30: Global HIV/AIDS Diagnostics Market Attractiveness Analysis, by Region, 2017–2025
Figure 31: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 32: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017 -2025
Figure 33: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 34: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 35: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 36: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 38: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test type, 2017-2025
Figure 39: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User, 2017-2025
Figure 40: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 41: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 42: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 43: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 44: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 45: Europe HIV/AIDS Diagnostic Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017 -2025
Figure 47: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017 -2025
Figure 48: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User
Figure 49: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 50: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 51: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 52: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 53: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 54: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 55: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product type, 2017-2025
Figure 56: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017-2025
Figure 57: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User, 2017-2025
Figure 58: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 60: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 61: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 62: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 63: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 64: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 65: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017- 2025
Figure 66: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by End Users, 2017-2025
Figure 67: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 68: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 69: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 70: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 71: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 72: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 73: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 74: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017-2025
Figure 75: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by End Users, 2017- 2025
Figure 76: Global HIV/AIDS Diagnostics Market Share Analysis, by Company (2016)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *